Multiple mutations are required for cancer development, and genome
sequencing has revealed that several cancers, including breast, have somatic
mutation spectra dominated by C-to-T transitions1–9.
Most of these mutations occur at hydrolytically disfavored10 non-methylated cytosines
throughout the genome, and are sometimes clustered8. Here, we show that the DNA cytosine deaminase
APOBEC3B (A3B) is a likely source of these mutations. A3B mRNA
is up-regulated in the majority of primary breast tumors and breast cancer cell
lines. Tumors that express high levels of A3B have twice as
many mutations as those that express low levels and are more likely to have
mutations in TP53. Endogenous A3B protein is predominantly
nuclear and the only detectable source of DNA C-to-U editing activity in breast
cancer cell line extracts. Knockdown experiments show that endogenous A3B
correlates with elevated levels of genomic uracil, increased mutation
frequencies, and C-to-T transitions. Furthermore, induced A3B over-expression
causes cell cycle deviations, cell death, DNA fragmentation, γ-H2AX
accumulation, and C-to-T mutations. Our data suggest a model in which
A3B-catalyzed deamination provides a chronic source of DNA damage in breast
cancers that could select TP53 inactivation and explain how
some tumors evolve rapidly and manifest heterogeneity.
The tobacco-specific nitrosamine
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
(NNK, 1) is a potent lung carcinogen in laboratory animals
and is believed to play a key role in the development of lung cancer
in smokers. Metabolic activation of NNK leads to the formation of
pyridyloxobutyl DNA adducts, a critical step in its mechanism of carcinogenesis.
In addition to DNA nucleobase adducts, DNA phosphate adducts can be
formed by pyridyloxobutylation of the oxygen atoms of the internucleotidic
phosphodiester linkages. We report the use of a liquid chromatography–nanoelectrospray
ionization–high-resolution tandem mass spectrometry technique
to characterize 30 novel pyridyloxobutyl DNA phosphate adducts in
calf thymus DNA (CT-DNA) treated with 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone
(NNKOAc, 2), a regiochemically activated form of NNK.
A 15N3-labeled internal standard was synthesized
for one of the most abundant phosphate adducts, dCp[4-oxo-4-(3-pyridyl)butyl]dC
(CpopC), and this standard was used to quantify CpopC and to estimate
the levels of other adducts in the NNKOAc-treated CT-DNA. Formation
of DNA phosphate adducts by NNK in vivo was further
investigated in rats treated with NNK acutely (0.1 mmol/kg once daily
for 4 days by subcutaneous injection) and chronically (5 ppm in drinking
water for 10, 30, 50, and 70 weeks). This study provides the first
comprehensive structural identification and quantitation of a panel
of DNA phosphate adducts of a structurally complex carcinogen and
chemical support for future mechanistic studies of tobacco carcinogenesis
in humans.
The compound 3-amino-2-quinoxalinecarbonitrile 1,4-dioxide (4) displays potent hypoxia-selective cytotoxicity in cell culture. This compound is structurally similar to the known hypoxia-selective DNA-damaging agent tirapazamine (1, TPZ), but the ability of 4 to cause DNA damage under low-oxygen conditions has not previously been characterized. The results presented here provide the first evidence that 4 causes reductively activated DNA damage under hypoxic conditions. The findings indicate that one-electron reduction of 4 by NADPH:cytochrome P450 reductase yields an oxygen-sensitive intermediate (5). This activated intermediate is rapidly destroyed by reaction with O2 under aerobic conditions, but goes forward to cause DNA damage under low-oxygen conditions. Analysis of the DNA damage indicates that reductive activation of 4 leads to production of a highly reactive, freely diffusible oxidizing radical that causes sequence-independent cleavage of the deoxyribose backbone and oxidative damage to the heterocyclic bases in duplex DNA. On the basis of the experiments reported here, the chemical nature of the DNA damage caused by redox-activated 4 is analogous to that reported previously for TPZ.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.